Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and

A Paolillo1, C Pozzilli, C Gasperini

  • 1Department of Neurological Sciences, University of Rome 'La Sapienza', Viale dell'Università 30, 00185, Rome, Italy.

Insights

Brain atrophy is an early MRI finding in relapsing remitting multiple sclerosis (RR MS). This brain volume reduction correlates with lesion load and disease severity, suggesting its utility as a progression marker.

Area of Science:

  • Neuroimaging
  • Neurology
  • Radiology

Background:

  • Brain atrophy is increasingly recognized as a significant indicator of neurological disease progression.
  • Multiple Sclerosis (MS) is a chronic inflammatory disease affecting the central nervous system, where brain volume changes are a key concern.

Purpose of the Study:

  • To evaluate supratentorial and infratentorial brain volumes in relapsing remitting multiple sclerosis (RR MS) patients compared to healthy controls.
  • To investigate the association between brain volumes, MRI-detected abnormalities, and clinical findings in RR MS.

Main Methods:

  • Two-dimensional MRI scans were acquired for 52 RR MS patients and 30 healthy subjects.
  • Supratentorial and infratentorial brain volumes were measured, alongside lesion load (Gd-enhancement, T2, T1 hypointense 'black holes') and corpus callosum area.
  • Correlations between volumetric MRI measures, lesion burden, and clinical data (disease duration, EDSS) were analyzed.

Main Results:

  • RR MS patients exhibited significantly reduced supratentorial, infratentorial brain volumes, and corpus callosum area compared to controls (P<0.01).
  • Supratentorial volume correlated with corpus callosum area (r=0.58) and T1 hypointense lesions (r=0.48), but not T2 lesions.
  • The infratentorial/supratentorial ratio associated with disease duration (r=-0.34) and EDSS score (r=-0.49).

Conclusions:

  • Brain atrophy is an early MRI finding in RR MS and is closely linked to the burden of 'black holes' (T1 hypointense lesions).
  • Relative brain volume measures, such as the infratentorial/supratentorial ratio, may enhance the detection of correlations between MRI findings and clinical disease progression.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...